Dying 'due to' or 'with' COVID-19: a cause of death analysis in hospitalised patients.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 6 8 2020
medline: 3 10 2020
entrez: 6 8 2020
Statut: ppublish

Résumé

The SARS-CoV-2 pandemic is accompanied by an ever-rising death toll attributed to coronavirus disease 2019 (COVID-19), but questions have persisted regarding deaths formally attributed to COVID-19. We aimed to provide an independent review of clinical features of patients who died during hospitalisation with a positive PCR test for SARS-CoV-2 and relate these to the reported cause of death. Between 23 March and 28 April 2020, a total of 162 patients with a positive SARS-CoV-2 PCR died in our NHS trust. COVID-19 infection was documented as the direct cause of death in 150 (93%). Review of the records revealed 138 (92%) patients had pulmonary infiltrates on chest radiography, and 146 (97%) required oxygen therapy. This retrospective review of cause of death has demonstrated that the overwhelming majority of hospitalised patients with positive SARS-CoV-2 PCR died as a direct consequence of COVID-19 infection.

Identifiants

pubmed: 32753516
pii: clinmed.2020-0440
doi: 10.7861/clinmed.2020-0440
pmc: PMC7539724
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e189-e190

Informations de copyright

© Royal College of Physicians 2020. All rights reserved.

Auteurs

Thomas A Slater (TA)

University of Leeds, Leeds, UK.

Sam Straw (S)

University of Leeds, Leeds, UK.

Michael Drozd (M)

University of Leeds, Leeds, UK.

Stephe Kamalathasan (S)

Leeds General Infirmary, Leeds, UK.

Alice Cowley (A)

Leeds General Infirmary, Leeds, UK.

Klaus K Witte (KK)

University of Leeds, Leeds, UK and consultant cardiologist, Leeds General Infirmary, Leeds, UK k.k.witte@leeds.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH